Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ioversol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112724035A details advanced HPLC purification for ioversol. Achieves 99.5% purity with water mobile phase, ensuring cost reduction and supply reliability.
Advanced ethanol recrystallization patent CN101337907B ensures high purity contrast agent intermediates with optimized supply chain efficiency and cost effectiveness.
Patent CN110156623A reveals buffer base method enhancing purity and yield for scalable contrast agent manufacturing supply chains significantly reducing impurity levels effectively for global buyers seeking stability now.
Advanced preparation of 5-chloroacetamide-N,N'-bi(2,3-dihydroxyl propyl)-2,4,6-triiodo-1,3-benzenedicarboxamide via optimized acyl chloride pathway for cost-effective contrast media manufacturing.
Novel patent CN119528755A details efficient ioversol impurity preparation enhancing supply chain stability and quality control for contrast agent manufacturing.
Patent CN114409566A details a high-yield synthesis of Ioversol Hydrolysate. Achieve >99.5% purity with simplified 2-step processing for cost-effective API manufacturing.